ECHDC3 is a mitochondrial enzyme, intricately involved in the metabolism of fatty acids-a process crucial for cellular energy homeostasis. Chemical activators of ECHDC3 operate through various intracellular signaling cascades and metabolic processes that ultimately lead to the functional enhancement of ECHDC3 activity. Certain activators can elevate intracellular levels of cAMP, thereby activating protein kinase A, which is known to phosphorylate a variety of proteins, potentially including ECHDC3, thereby enhancing its role in fatty acid metabolism. Furthermore, other compounds can increase the activity of AMPK, a key cellular energy sensor, which phosphorylates different targets. This phosphorylation cascade may indirectly boost ECHDC3 functional activity by modulating the enzyme's role within the broader context of cellular energy utilization and fatty acid catabolism.
Additionally, activators that increase the cellular concentration of substrates or cofactors necessary for ECHDC3's enzymatic reactions also play a significant role. Compounds that serve as precursors or direct providers of important metabolites such as NAD+, Acetyl-CoA, and fatty acyl-CoA derivatives can potentially enhance the activity of ECHDC3. The availability of these molecules is crucial for the beta-oxidation of fatty acids in the mitochondria, where ECHDC3 operates. Furthermore, agonists of peroxisome proliferator-activated receptors (PPARs) indirectly contribute to the upregulation of genes involved in lipid metabolism, which might lead to an increase in ECHDC3 activity due to a higher demand for its enzymatic function in these pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels which can enhance protein kinase A (PKA) activity leading to the phosphorylation and activation of ECHDC3. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
AMP-activated protein kinase (AMPK) activator that can phosphorylate downstream targets, potentially increasing ECHDC3 activity as part of fatty acid metabolism regulation. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $56.00 $186.00 $296.00 $655.00 $2550.00 $3500.00 $10500.00 | 4 | |
Coenzyme involved in redox reactions, can indirectly enhance ECHDC3 activity by providing necessary cofactors for beta-oxidation of fatty acids. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $92.00 $269.00 $337.00 $510.00 $969.00 | 4 | |
Precursor to NAD+, can increase the availability of NAD+ thus potentially enhancing the activity of ECHDC3 in fatty acid oxidation processes. | ||||||
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $33.00 $77.00 $175.00 | 3 | |
Facilitates the transport of fatty acids into mitochondria, potentially enhancing ECHDC3 activity by increasing substrate availability for fatty acid oxidation. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $30.00 $45.00 $120.00 $200.00 | 5 | |
Peroxisome proliferator-activated receptor (PPAR) agonist, indirectly increases the expression of genes involved in fatty acid metabolism, potentially increasing ECHDC3 activity. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
PPARγ agonist, can indirectly increase ECHDC3 activity by enhancing the expression of genes involved in fatty acid metabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
PPARγ agonist that can indirectly lead to enhanced ECHDC3 activity by modulating gene expression related to fatty acid metabolism. | ||||||
Acetyl coenzyme A trisodium salt | 102029-73-2 | sc-210745 sc-210745A sc-210745B | 1 mg 5 mg 1 g | $46.00 $80.00 $5712.00 | 3 | |
Central metabolite in fatty acid synthesis that can serve as a substrate for ECHDC3, indirectly increasing its activity. | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $88.00 $190.00 | 1 | |
Endogenous PPARα agonist, can increase the expression of genes involved in lipid metabolism, thereby potentially enhancing ECHDC3 activity. |